Harel Insurance Investments & Financial Services’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$534K Buy
1,370
+750
+121% +$317K ﹤0.01% 244
2026
Q1
$293K Buy
620
+329
+113% +$166K ﹤0.01% 264
2025
Q4
$136K Buy
+291
New +$135K ﹤0.01% 299
2025
Q1
Sell
-382
Closed -$115K 509
2024
Q4
$115K Buy
+382
New +$134K ﹤0.01% 244
2021
Q3
Sell
-4,314
Closed -$2.91M 729
2021
Q2
$2.91M Buy
+4,314
New +$879K 0.06% 147
2020
Q2
Sell
-223
Closed -$20K 536
2020
Q1
$20K Buy
+223
New +$28.9K ﹤0.01% 346
2016
Q4
Sell
-250
Closed -$19K 398
2016
Q3
$19K Buy
+250
New +$19.1K ﹤0.01% 313

Other funds holding HCA

Harel Insurance Investments & Financial Services's HCA Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services increased its HCA Healthcare (HCA) stake by 121% in Q2 2026, buying an estimated $317K and bringing the position to 1,370 shares worth $534K. The position accounts for ﹤0.01% of the portfolio, ranked #244.

Harel Insurance Investments & Financial Services first reported a position in HCA in Q3 2016 and has held it in 7 quarters since. The position peaked at $2.91M in Q2 2021. 750 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Harel Insurance Investments & Financial Services held 1,370 shares of HCA Healthcare worth $534K as of Q2 2026.
  • Harel Insurance Investments & Financial Services bought 750 HCA Healthcare shares in Q2 2026, an estimated $317K.
  • HCA Healthcare made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #244 holding.
  • Harel Insurance Investments & Financial Services first reported a position in HCA Healthcare in Q3 2016 and has held it in 7 quarters since.
  • Harel Insurance Investments & Financial Services's HCA Healthcare position peaked at $2.91M in Q2 2021.
  • 750 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.